% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Schaffrath:1044407,
author = {Schaffrath, Kim and Ingensiep, Claudia and Müller, Frank
and Walter, Peter and Johnen, Sandra},
title = {{E}ffects of taurine, brimonidine and betaxolol on
oscillation modulation and stimulation efficiency in
degenerated rd10 mouse retinas},
journal = {Scientific reports},
volume = {15},
number = {1},
issn = {2045-2322},
address = {[London]},
publisher = {Springer Nature},
reportid = {FZJ-2025-03170},
pages = {20209},
year = {2025},
note = {The authors thank the Institute of Laboratory Animal
Science (Faculty of Medicine, RWTH Aachen University) for
support, Anne Rohn (Department of Ophthalmology, University
Hospital RWTH Aachen) for excellent technical assistance,
and Sabine Diarra for her efforts to prepare the grant
application for the Pro Retina Foundation.Open Access
funding enabled and organized by Projekt DEAL.},
abstract = {The rd10 mouse is a widely used model for degenerative
retinal diseases such as retinitis pigmentosa(RP). Its
retina shows rhythmic spontaneous activity at a frequency of
three to seven Hz, andthe retinal ganglion cells (RGCs) are
less electrically excitable. We hypothesize that the
electricalexcitability can be improved by suppressing the
oscillations using the neuroprotective
drugs2-aminoethanesulphonic acid (taurine), brimonidine and
betaxolol. These are involved in calciumhomeostasis and may
play a crucial role in neuroprotection and excitotoxicity by
preventing Ca2+overload. Spontaneous activity and responses
to electrical stimulation of isolated retinas from3- to
4-month-old rd10 mice were recorded using multielectrode
arrays. At defined times, theneuroprotectants were
repeatedly added to the medium according to a standardized
protocol toanalyze the reproducibility and reversibility of
their effects. Taurine and betaxolol significantly
reducedoscillations and bursting behavior and ameliorated
electrical efficiency. Brimonidine only reduced thefrequency
of oscillations. The effects on oscillation, spontaneous
firing frequency, bursting behaviorand stimulation
efficiency were reproducible and reversible. The drugs
tested appear to be promisingtherapeutic candidates for
improving the residual function of RGCs. They will be
further investigatedand combined with other RP treatments,
such as retinal prostheses, in the future.},
cin = {IBI-1 / INW-1},
ddc = {600},
cid = {I:(DE-Juel1)IBI-1-20200312 / I:(DE-Juel1)INW-1-20231219},
pnm = {5244 - Information Processing in Neuronal Networks
(POF4-524) / GRK 2610 - GRK 2610: Innovative Schnittstellen
zur Retina für optimiertes künstliches Sehen -
InnoRetVision (424556709)},
pid = {G:(DE-HGF)POF4-5244 / G:(GEPRIS)424556709},
typ = {PUB:(DE-HGF)16},
doi = {10.1038/s41598-025-06440-9},
url = {https://juser.fz-juelich.de/record/1044407},
}